Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "contact"

112 News Found

Presence of Mpox virus of West African clade 2 confirmed in isolated patient
News | September 10, 2024

Presence of Mpox virus of West African clade 2 confirmed in isolated patient

This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards


Aptar Pharma and Pulmotree to develop and promote Kolibri non-propellant liquid inhaler platform
News | September 10, 2024

Aptar Pharma and Pulmotree to develop and promote Kolibri non-propellant liquid inhaler platform

Agreement further expands Aptar Pharma’s leading respiratory portfolio


Suspected Mpox case under investigation
News | September 09, 2024

Suspected Mpox case under investigation

The patient has been isolated in a designated hospital and is currently stable


Health Minister Nadda reviews Monkeypox situation and preparedness
Policy | August 19, 2024

Health Minister Nadda reviews Monkeypox situation and preparedness

Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management


Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital
News | June 27, 2024

Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital

Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation


Fischer Medical Venture and BluSim Tech partner to redefine elderly care
Healthcare | June 10, 2024

Fischer Medical Venture and BluSim Tech partner to redefine elderly care

his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio


Lupin completes acquisition of two brands from Sanofi in Europe and Canada
News | June 08, 2024

Lupin completes acquisition of two brands from Sanofi in Europe and Canada

The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas


IGC Pharma announces patient enrollment at Neurostudies in Phase 2 trial investigating IGC-AD1
News | May 29, 2024

IGC Pharma announces patient enrollment at Neurostudies in Phase 2 trial investigating IGC-AD1

Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's


Cresset opens new new India HQ in Bengaluru to tap potential of APAC market
News | May 17, 2024

Cresset opens new new India HQ in Bengaluru to tap potential of APAC market

Cresset’s new India site will support the growing demands of Cresset’s APAC customer base


Viatris launches RYZUMVl 0.75% in US
News | April 02, 2024

Viatris launches RYZUMVl 0.75% in US

The average time of dilation lasts three to eight hours